CUZ | Ticker Profile - Titan Protect

CUZ

Cousins Properties Incorporated

Real Estate · REIT - Office · NYQ

$27.69

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.4B

Total market value of the company

Trailing P/E

N/A

Forward P/E

89.47

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.8%

Year-over-year revenue change

Profit Margin

-0.5%

How much profit the company keeps from each dollar of revenue

ROE

-0.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$28.50

+3% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 12 analysts covering this stock

About Cousins Properties Incorporated

Cousins Properties Incorporated is a fully integrated, self-administered and self-managed real estate investment trust. The Company acting through its operating partnership, Cousins Properties LP, primarily invests in Class A office buildings located in high growth Sun Belt markets. Cousins creates shareholder value through its extensive expertise in the development, acquisition, leasing, and management of high-quality real estate assets. The Company has a comprehensive strategy in place based on a simple platform, trophy assets, and opportunistic investments. Cousins Properties Incorporated was founded in 1958 and is based in Georgia, Atlanta.

https://www.cousins.com

Country: United States Employees: 351 Industry: REIT - Office

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.678

Good returns relative to risk taken

Kelly Fraction

0.0498

Modest edge detected — smaller position warranted

Calmar Ratio

0.521

Acceptable balance between returns and drawdown risk

Annual Return

15.3%

Historical annualised return based on price data

Max Drawdown

-29.4%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.20

Moves slightly more than the broader market

52W High

$30.81

10% below the year high

52W Low

$21.03

32% above the year low

Avg Volume

2,009,418

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.6

Days it would take all short sellers to cover — higher means more crowded

Short % Float

10.9%

Elevated short interest — bears are positioned against this

Div Yield

477.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.03

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

84.33

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.35

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.31

Like current ratio but excludes inventory — stricter test

Gross Margin

67.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

22.1%

Profit from core operations before interest and tax

Free Cash Flow

$93M

Positive — the business generates more cash than it spends

Revenue (TTM)

$998M

Total revenue over the last 12 months

Net Income

$-5,250,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$34.00

Target Median

$28.50

Target Low

$24.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go